Autres langues AstraZeneca Pharma India Limited

Actions

ASTRAZEN

INE203A01020

Marché Fermé - Bombay S.E. Autres places de cotation 12:18:15 16/05/2024			Varia. 5j.	Varia. 1 janv.
5 639 ^INR	+2,88 %		+6,18 %	+2,16 %

08/04	AstraZeneca Pharma India Limited approuve la nomination de Bhavana Agrawal en tant que directeur et directeur à temps plein	CI
25/03	AstraZeneca Pharma India Limited nomme Vinay Sharma au poste de Business Unit Head - Rare Disease, à compter du 1er juillet 2024	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

AstraZeneca Pharma India Limited Approves Appointment of Bhavana Agrawal as Director and Whole Time Director	08/04
AstraZeneca Pharma India Limited Appoints Vinay Sharma as Business Unit Head - Rare Disease, Effective July 1, 2024	25/03
AstraZeneca, Mankind Pharma Tie Up for Exclusive Distribution of Asthma Drug Symbicort in India	11/03
Astrazeneca Pharma India Ltd and Mankind Pharma Partner to Accelerate Access to Asthma Medicine for Patients in India	11/03
Astrazeneca Pharma India Limited Announces Board Changes	20/02
AstraZeneca Pharma India Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	08/02
AstraZeneca Pharma India Limited Announces Board Changes	08/02
AstraZeneca Pharma India Limited Announces Directorate Appointments	07/02
AstraZeneca Gets Indian Drug Regulator's Nod to Import Andexanet Alfa Powder for Solution for Infusion	22/01
Astrazeneca Pharma to Launch Breast Cancer Treatment Drug in India in January 2024	21/12
India's Nifty set for muted open after steep drop	21/12
Astrazeneca Pharma India Limited Appoints Hooi-Bien Chuah as Additional Director (Non-Executive)	09/11
AstraZeneca Pharma India Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	09/11
AstraZeneca Gets Indian Drug Regulator's Nod to Import Pharmaceutical Formulations for Palivizumab	02/10/23
Astrazeneca Pharma India Limited Receives Permission to Import Pharmaceutical Formulations Of New Drug For Sale Or For Distribution In Form CT-20 From Central Drugs Standard Control Organisation For Palivizumab	30/09/23
AstraZeneca Pharma India Limited Announces Management Changes	29/09/23
Astrazeneca Pharma India Limited Announces Retirement of Rajesh Marwaha as Whole-Time Director	29/09/23
AstraZeneca Pharma India Limited Appoints Praveen Akkinepally as the Business Unit Head Oncology with Effect from November 1, 2023	15/09/23
AstraZeneca Pharma India Limited Approves Dividend for the Financial Year 2022-2023	17/08/23
AstraZeneca Pharma India Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	14/08/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues AstraZeneca Pharma India Limited

Actions

ASTRAZEN

INE203A01020

Autres langues

Filtres